Aging-associated mechanisms of atrial fibrillation progression and their therapeutic potential

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia, with a particularly high prevalence in the elderly. As the global aging population rapidly expands, it is increasingly important to examine how alterations to the aging heart contribute to an increased AF susceptibility. This work critically reviews the key molecular mechanisms that may underpin the complex association between aging and AF. Moreover, we identify emerging novel opportunities for therapeutic intervention that may be able to prevent and/or improve the current treatment paradigms for age-related AF. This review contributes to a holistic understanding of the intricate relationship between aging and AF.

Keywords

Atrial fibrillation / arrhythmia / aging / myocardial remodeling / ryanodine receptor / therapeutic targets

References

[1] Elliott AD,Van Gelder IC,Sanders P.Epidemiology and modifiable risk factors for atrial fibrillation.Nat Rev Cardiol2023;20:404-17

[2] Chen Q,Cheng J.Atrial fibrillation in aging population.Aging Med2018;1:67-74 PMCID:PMC6880740

[3] Chen C,Wang J.Digital health for aging populations.Nat Med2023;29:1623-30

[4] López-Otín C,Partridge L,Kroemer G.Hallmarks of aging: an expanding universe.Cell2023;186:243-78

[5] López-Otín C,Partridge L,Kroemer G.The hallmarks of aging.Cell2013;153:1194-217 PMCID:PMC3836174

[6] Partridge L,Kennedy BK.The quest to slow ageing through drug discovery.Nat Rev Drug Discov2020;19:513-32

[7] Haïssaguerre M,Shah DC.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.N Engl J Med1998;339:659-66

[8] Brundel BJJM,Hills MT,Lip GYH.Atrial fibrillation.Nat Rev Dis Primers2022;8:21

[9] Wijffels MCEF,Dorland R.Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats.Circulation1995;92:1954-68

[10] Camm AJ,Mittal S.The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review.J Am Coll Cardiol2022;79:1932-48

[11] Dye CA,Khan A.The era of rhythm control: a review of the epidemiology and clinical impact of anti-arrhythmic medications in atrial fibrillation.Pharmacoepidemiology2023;2:81-97

[12] Tisdale JE,Campbell KB.Drug-induced arrhythmias: a scientific statement from the American heart association.Circulation2020;142:e214-33

[13] Hindricks G,Dagres N.2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J2021;42:373-498

[14] Brooks S,Wohlmuth P.Insights into ablation of persistent atrial fibrillation: Lessons from 6-year clinical outcomes.J Cardiovasc Electrophysiol2018;29:257-63

[15] Jaakkola S,Biancari F.Predicting unsuccessful electrical cardioversion for acute atrial fibrillation (from the AF-CVS Score).Am J Cardiol2017;119:749-52

[16] Lahiri SK,Wehrens XHT.Mechanisms underlying pathological Ca²⁺ handling in diseases of the heart.Pflugers Arch2021;473:331-47

[17] Biliczki P,Girmatsion Z.Age-related regulation and region-specific distribution of ion channel subunits promoting atrial fibrillation in human left and right atria.Europace2019;21:1261-9

[18] Heijman J,Nattel S.Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.Circ Res2014;114:1483-99

[19] Turdi S,Li J.AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction.Aging Cell2010;9:592-606 PMCID:PMC2910211

[20] Qin F,Lancel S.Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart.J Am Heart Assoc2013;2:e000184 PMCID:PMC3828801

[21] Guo KK.Cardiac overexpression of alcohol dehydrogenase (ADH) alleviates aging-associated cardiomyocyte contractile dysfunction: role of intracellular Ca²⁺ cycling proteins.Aging Cell2006;5:259-65

[22] Gergs U,Langguth F.Alterations of protein expression of phospholamban, ZASP and plakoglobin in human atria in subgroups of seniors.Sci Rep2019;9:5610 PMCID:PMC6449388

[23] Salameh A,Fleischmann B.The aging heart: changes in the pharmacodynamic electrophysiological response to verapamil in aged rabbit hearts.J Physiol Pharmacol2010;61:141-51

[24] Isenberg G,Rueckschloss U.Ca²⁺ transients of cardiomyocytes from senescent mice peak late and decay slowly.Cell Calcium2003;34:271-80

[25] Valdés Á,Barrios G.NOX inhibition improves β-adrenergic stimulated contractility and intracellular calcium handling in the aged rat heart.Int J Mol Sci2018;19:2404 PMCID:PMC6121436

[26] Zhu X,Hajjar RJ,Schmidt U.Altered Ca²⁺ sparks and gating properties of ryanodine receptors in aging cardiomyocytes.Cell Calcium2005;37:583-91

[27] Wongcharoen W,Chen YJ.Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents.Heart Rhythm2007;4:1338-49

[28] Cooper LL,Lu Y.Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca²⁺ handling in ageing rabbit hearts.J Physiol2013;591:5895-911 PMCID:PMC3872760

[29] Marx SO.Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.J Mol Cell Cardiol2013;58:225-31 PMCID:PMC4042628

[30] Wehrens XH,Reiken S,Wronska A.Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.Proc Natl Acad Sci USA2006;103:511-8 PMCID:PMC1334677

[31] Uchinoumi H,Oda T.CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.J Mol Cell Cardiol2016;98:62-72 PMCID:PMC5026590

[32] Wehrens XH,Reiken SR.Ca²⁺/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.Circ Res2004;94:e61-70

[33] Campbell HM,Abu-Taha I.Loss of SPEG inhibitory phosphorylation of ryanodine receptor type-2 promotes atrial fibrillation.Circulation2020;142:1159-72 PMCID:PMC7508800

[34] Mendonca N,Bedja D.Dysregulation of cardiac CaMKII pathway is increased in aging and chronic inflammation.FASEB J2021;35:

[35] Beavers DL,Chiang DY.Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases.Cardiovasc Res2014;103:198-205 PMCID:PMC4809974

[36] Beavers DL,Ather S.Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization.J Am Coll Cardiol2013;62:2010-9 PMCID:PMC3830688

[37] Munro ML,Wang Q.Junctophilin-2 in the nanoscale organisation and functional signalling of ryanodine receptor clusters in cardiomyocytes.J Cell Sci2016;129:4388-98 PMCID:PMC5201013

[38] Reynolds JO,Wang Q.Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca²⁺ release.Int J Cardiol2016;225:371-80 PMCID:PMC5101129

[39] Lyu Y,Lee Y.Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart.NPJ Aging Mech Dis2021;7:16 PMCID:PMC8163749

[40] Choi S,Baudot M.Aging alters the formation and functionality of signaling microdomains between L-type calcium channels and β2-adrenergic receptors in cardiac pacemaker cells.Front Physiol2022;13:805909 PMCID:PMC9065441

[41] Luo X,Liu Z.Ageing increases cardiac electrical remodelling in rats and mice via NOX4/ROS/CaMKII-mediated calcium signalling.Oxid Med Cell Longev2022;2022:8538296 PMCID:PMC8979732

[42] Anyukhovsky EP,Plotnikov A.Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis.Cardiovasc Res2002;54:462-9

[43] Herraiz-Martínez A,Llach A.Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes.Cardiovasc Res2015;106:76-86 PMCID:PMC4362404

[44] Feridooni HA,Howlett SE.How cardiomyocyte excitation, calcium release and contraction become altered with age.J Mol Cell Cardiol2015;83:62-72

[45] Joseph LC,Homan EA.The mitochondrial calcium uniporter promotes arrhythmias caused by high-fat diet.Sci Rep2021;11:17808 PMCID:PMC8426388

[46] Liu C,Dan Q.Mitochondrial dysfunction contributes to aging-related atrial fibrillation.Oxid Med Cell Longev2021;2021:5530293 PMCID:PMC8102104

[47] Liguori I,Curcio F.Oxidative stress, aging, and diseases.Clin Interv Aging2018;13:757-72 PMCID:PMC5927356

[48] Harman D.Aging: a theory based on free radical and radiation chemistry.J Gerontol1956;11:298-300

[49] Martínez de Toda I, Ceprián N, Díaz-Del Cerro E, De la Fuente M. The role of immune cells in oxi-inflamm-aging.Cells2021;10:2974 PMCID:PMC8616159

[50] Gladyshev VN.The free radical theory of aging is dead. Long live the damage theory!.Antioxid Redox Signal2014;20:727-31 PMCID:PMC3901353

[51] Tan BL,Liew WP.Antioxidant and oxidative stress: a mutual interplay in age-related diseases.Front Pharmacol2018;9:1162 PMCID:PMC6204759

[52] Maldonado E,Urbina F.Aging hallmarks and the role of oxidative stress.Antioxidants2023;12:651 PMCID:PMC10044767

[53] Iakovou E.A comprehensive overview of the complex role of oxidative stress in aging, the contributing environmental stressors and emerging antioxidant therapeutic interventions.Front Aging Neurosci2022;14:827900 PMCID:PMC9234325

[54] Peoples JN,Ghazal N,Kwong JQ.Mitochondrial dysfunction and oxidative stress in heart disease.Exp Mol Med2019;51:1-13 PMCID:PMC6923355

[55] Reilly SN,Nahar K.Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.Circulation2011;124:1107-17

[56] Rudolph V,Rudolph TK.Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.Nat Med2010;16:470-4 PMCID:PMC2880896

[57] Youn JY,Zhang Y.Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.J Mol Cell Cardiol2013;62:72-9 PMCID:PMC3735724

[58] Xie W,Reiken SR.Mitochondrial oxidative stress promotes atrial fibrillation.Sci Rep2015;5:11427 PMCID:PMC4501003

[59] D'Oria R,Leonardini A.The role of oxidative stress in cardiac disease: from physiological response to injury factor.Oxid Med Cell Longev2020;2020:5732956 PMCID:PMC7244977

[60] Liu H,Liu D.Manganese superoxide dismutase as a novel oxidative stress biomarker for predicting paroxysmal atrial fibrillation.J Clin Med2022;11:5131 PMCID:PMC9457192

[61] Kim YH,Lee JH.Gene expression profiling of oxidative stress on atrial fibrillation in humans.Exp Mol Med2003;35:336-49

[62] Kozakiewicz M,Krzywińska O.Changes in the blood antioxidant defense of advanced age people.Clin Interv Aging2019;14:763-71 PMCID:PMC6507109

[63] Watts M,Dherange P.Decreased bioavailability of hydrogen sulfide links vascular endothelium and atrial remodeling in atrial fibrillation.Redox Biol2021;38:101817 PMCID:PMC7732878

[64] Tesauro M,Rovella V.Arterial ageing: from endothelial dysfunction to vascular calcification.J Intern Med2017;281:471-82

[65] Chong E,Hsiao YW.Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation.Heart Rhythm2015;12:1046-56

[66] Dong Q,Li X.Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca²⁺ cycling proteins.J Transl Med2014;12:323 PMCID:PMC4278670

[67] Csengeri D,Di Castelnuovo A.Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes.Eur Heart J2021;42:1170-7

[68] Baczkó I.Resveratrol and derivatives for the treatment of atrial fibrillation.Ann N Y Acad Sci2015;1348:68-74

[69] Wang C.Hydrogen-rich saline mitigates pressure overload-induced cardiac hypertrophy and atrial fibrillation in rats via the JAK-STAT signalling pathway.J Int Med Res2020;48:300060520936415 PMCID:PMC7416141

[70] Mighiu AS,Ziberna K.Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.Cardiovasc Res2021;117:2354-64 PMCID:PMC8479801

[71] Kim YM,Zhang YH.A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.Circ Res2005;97:629-36

[72] Patti G,Candura D.Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.Circulation2006;114:1455-61

[73] Shiroshita-Takeshita A,Lavoie J.Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.Circulation2004;110:2313-9

[74] Zheng Z,Jiang L.Perioperative rosuvastatin in cardiac surgery.N Engl J Med2016;374:1744-53

[75] Murphy C,Cranfield CG.The role of structure and biophysical properties in the pleiotropic effects of statins.Int J Mol Sci2020;21:8745 PMCID:PMC7699354

[76] Rahimi K,McGale P.Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.BMJ2011;342:d1250

[77] El Assar M, Álvarez-Bustos A, Sosa P, Angulo J, Rodríguez-Mañas L. Effect of physical activity/exercise on oxidative stress and inflammation in muscle and vascular aging.Int J Mol Sci2022;23:8713 PMCID:PMC9369066

[78] Mozaffarian D,Psaty BM.Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study.Circulation2008;118:800-7 PMCID:PMC3133958

[79] Elliott AD,Mahajan R.An exercise and physical activity program in patients with atrial fibrillation: the ACTIVE-AF randomized controlled trial.JACC Clin Electrophysiol2023;9:455-65

[80] Barth AS,Arnoldi E.Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature.Circ Res2005;96:1022-9

[81] Mayr M,Weir G.Combined metabolomic and proteomic analysis of human atrial fibrillation.J Am Coll Cardiol2008;51:585-94

[82] Huang Y,Zhou Y.Amino acid profile alteration in age-related atrial fibrillation.J Transl Med2024;22:259 PMCID:PMC10925006

[83] Pool L,de Groot NMS.The role of mitochondrial dysfunction in atrial fibrillation: translation to druggable target and biomarker discovery.Int J Mol Sci2021;22:8463 PMCID:PMC8395135

[84] Brand MD,Perevoshchikova IV.The role of mitochondrial function and cellular bioenergetics in ageing and disease.Br J Dermatol2013;169:1-8 PMCID:PMC4321783

[85] Lima T,Mottis A.Pleiotropic effects of mitochondria in aging.Nat Aging2022;2:199-213

[86] Chistiakov DA,Revin VV,Bobryshev YV.Mitochondrial aging and age-related dysfunction of mitochondria.Biomed Res Int2014;2014:238463 PMCID:PMC4003832

[87] Miwa S,Chini E.Mitochondrial dysfunction in cell senescence and aging.J Clin Invest2022;132:e158447 PMCID:PMC9246372

[88] Thiedemann KU.Left atrial ultrastructure in mitral valvular disease.Am J Pathol1977;89:575-604 PMCID:PMC2032253

[89] Ausma J,Thoné F,Allessie M.Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.Circulation1997;96:3157-63

[90] Mason FE,Alhussini K,Voigt N.Cellular and mitochondrial mechanisms of atrial fibrillation.Basic Res Cardiol2020;115:72 PMCID:PMC7704501

[91] Liang H.PGC-1α: a key regulator of energy metabolism.Adv Physiol Educ2006;30:145-51

[92] Valli H,Chadda KR.Age-dependent atrial arrhythmic phenotype secondary to mitochondrial dysfunction in Pgc-1β deficient murine hearts.Mech Ageing Dev2017;167:30-45 PMCID:PMC5652526

[93] Harada M,Sobue Y.Metabolic considerations in atrial fibrillation - mechanistic insights and therapeutic opportunities.Circ J2017;81:1749-57

[94] Zhang D,Li J.DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD⁺ depletion in experimental atrial fibrillation.Nat Commun2019;10:1307 PMCID:PMC6428932

[95] Mangerich A.Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation.Oxid Med Cell Longev2012;2012:321653 PMCID:PMC3459245

[96] Hosseini L,Mahmoudi J.Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions.Biogerontology2019;20:381-95

[97] Mehmel M,Spitz U.Nicotinamide riboside-the current state of research and therapeutic uses.Nutrients2020;12:1616 PMCID:PMC7352172

[98] Pool L,Manintveld OC.The HF-AF ENERGY trial: nicotinamide riboside for the treatment of atrial fibrillation in heart failure patients.Cardiovasc Drugs Ther2023;37:1243-8 PMCID:PMC10721700

[99] Airhart SE,Risler LJ.An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.PLoS One2017;12:e0186459 PMCID:PMC5718430

[100] Franceschi C,Parini P,Santoro A.Inflammaging: a new immune-metabolic viewpoint for age-related diseases.Nat Rev Endocrinol2018;14:576-90

[101] Ferrucci L.Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.Nat Rev Cardiol2018;15:505-22 PMCID:PMC6146930

[102] Chung MK,Sprecher D.C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.Circulation2001;104:2886-91

[103] Guo Y,Apostolakis S.Inflammation in atrial fibrillation.J Am Coll Cardiol2012;60:2263-70

[104] Dobrev D,Hiram R,Nattel S.Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology.Nat Rev Cardiol2023;20:145-67 PMCID:PMC9477170

[105] Nso N,Metzl M.Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge.J Arrhythm2021;37:1-10 PMCID:PMC7896450

[106] Zhou X.Evidence for inflammation as a driver of atrial fibrillation.Front Cardiovasc Med2020;7:62 PMCID:PMC7201086

[107] Jansen HJ,Gillis AM.Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease.Heart Rhythm O22020;1:147-59 PMCID:PMC8183954

[108] Lazzerini PE,Laghi-Pasini F.Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis.Eur Heart J2017;38:1717-27

[109] Rossiello F,Passos JF.Telomere dysfunction in ageing and age-related diseases.Nat Cell Biol2022;24:135-47 PMCID:PMC8985209

[110] Sweeney M,Gil J.Therapeutic opportunities for senolysis in cardiovascular disease.FEBS J2023;290:1235-55 PMCID:PMC10952275

[111] Triana-Martínez F,Da Silva-Álvarez S.Identification and characterization of cardiac glycosides as senolytic compounds.Nat Commun2019;10:4731 PMCID:PMC6803708

[112] Huang Y,Sinha SC,Gan L.Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders.Mol Neurodegener2023;18:79 PMCID:PMC10634099

[113] Decout A,Venkatraman S.The cGAS-STING pathway as a therapeutic target in inflammatory diseases.Nat Rev Immunol2021;21:548-69 PMCID:PMC8029610

[114] McHugh D.Senescence and aging: causes, consequences, and therapeutic avenues.J Cell Biol2018;217:65-77 PMCID:PMC5748990

[115] Sebastian-Valverde M.The NLRP3 inflammasome as a critical actor in the inflammaging process.Cells2020;9:1552 PMCID:PMC7348816

[116] Latz E.NLRP3 inflammasome activation in inflammaging.Semin Immunol2018;40:61-73

[117] Song J,Wu J.Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation.J Clin Invest2023;133:e167517 PMCID:PMC10541185

[118] Zhang Y,Li B.Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome.Cardiovasc Res2022;118:785-97

[119] Yao C,Scott L Jr.Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation.Circulation2018;138:2227-42 PMCID:PMC6252285

[120] Marín-Aguilar F,Alcocer-Gómez E.NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice.Aging Cell2020;19:e13050 PMCID:PMC6974709

[121] Willar B,Fitzgibbons TP.Epicardial adipocytes in the pathogenesis of atrial fibrillation: An update on basic and translational studies.Front Endocrinol2023;14:1154824 PMCID:PMC10067711

[122] Patel KHK,Se Liebers C.Epicardial adipose tissue as a mediator of cardiac arrhythmias.Am J Physiol Heart Circ Physiol2022;322:H129-44 PMCID:PMC8742735

[123] Abe I,Kondo H.Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation.Heart Rhythm2018;15:1717-27

[124] Kira S,Ishii Y.Role of angiopoietin-like protein 2 in atrial fibrosis induced by human epicardial adipose tissue: Analysis using an organo-culture system.Heart Rhythm2020;17:1591-601

[125] Meulendijks ER,Kawasaki M.Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation.J Transl Med2023;21:366 PMCID:PMC10245533

[126] Hou K,Chen XY.Microbiota in health and diseases.Signal Transduct Target Ther2022;7:135 PMCID:PMC9034083

[127] Carding S,Vipond DT,Owen LJ.Dysbiosis of the gut microbiota in disease.Microb Ecol Health Dis2015;26:26191 PMCID:PMC4315779

[128] Wilmanski T,Rappaport N.Gut microbiome pattern reflects healthy ageing and predicts survival in humans.Nat Metab2021;3:274-86 PMCID:PMC8169080

[129] Gawałko M,Saljic A.Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.Cardiovasc Res2022;118:2415-27 PMCID:PMC9400433

[130] Yu L,Huang B.A potential relationship between gut microbes and atrial fibrillation: trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.Int J Cardiol2018;255:92-8

[131] Svingen GFT,Ueland PM.Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.Int J Cardiol2018;267:100-6

[132] Zuo K,Li K.Different types of atrial fibrillation share patterns of gut microbiota dysbiosis.mSphere2020;5:e00071-20 PMCID:PMC7082137

[133] Palmu J,Ortega-Alonso A.Gut microbiome and atrial fibrillation-results from a large population-based study.EBioMedicine2023;91:104583 PMCID:PMC10165189

[134] Eghbali M,Robinson TF,Blumenfeld OO.Collagen accumulation in heart ventricles as a function of growth and aging.Cardiovasc Res1989;23:723-9

[135] Wynn TA.Cellular and molecular mechanisms of fibrosis.J Pathol2008;214:199-210 PMCID:PMC2693329

[136] Trial J.Changes in cardiac resident fibroblast physiology and phenotype in aging.Am J Physiol Heart Circ Physiol2018;315:H745-55 PMCID:PMC6737453

[137] Cieslik KA,Entman ML.Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway.Am J Pathol2011;179:1792-806 PMCID:PMC3181380

[138] Zhang R,Huang XR.C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.Hypertension2010;55:953-60

[139] Cieslik KA,Carlson S,Entman ML.Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels.FASEB J2013;27:1761-71 PMCID:PMC3606539

[140] Neilan TG,Shah RV.Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.JACC Cardiovasc Imaging2013;6:672-83

[141] Sohns C.Atrial fibrillation and cardiac fibrosis.Eur Heart J2020;41:1123-31

[142] King JB,Suksaranjit P.Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation.J Am Coll Cardiol2017;70:1311-21

[143] Ni L,Nie J.Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice.Cardiovasc Res2022;118:2805-18 PMCID:PMC9586567

[144] Scholz B,Hamer S.HDAC (histone deacetylase) inhibitor valproic acid attenuates atrial remodeling and delays the onset of atrial fibrillation in mice.Circ Arrhythm Electrophysiol2019;12:e007071 PMCID:PMC6426346

[145] Zhao S,Lahiri SK.Atrial proteomic profiling reveals a switch towards profibrotic gene expression program in CREM-IbΔC-X mice with persistent atrial fibrillation.J Mol Cell Cardiol2024;190:1-12

[146] Travers JG,Robbins J,Blaxall BC.Cardiac fibrosis: the fibroblast awakens.Circ Res2016;118:1021-40 PMCID:PMC4800485

[147] Cieslik KA,Entman ML.Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart.FASEB J2015;29:3160-70 PMCID:PMC4511196

[148] Vidal R,Braeuning C.Transcriptional heterogeneity of fibroblasts is a hallmark of the aging heart.JCI Insight2019;4:131092 PMCID:PMC6948853

[149] Xie J,Hu C.Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation.Oncotarget2017;8:57981-90 PMCID:PMC5601627

[150] Nicin L,Luxán G.Fibroblast-mediated intercellular crosstalk in the healthy and diseased heart.FEBS Lett2022;596:638-54

[151] Tsuruda T,Boerrigter G.Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor.Circ Res2002;90:128-34

[152] López-Andrés N,Labat C.Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice.Hypertension2013;61:120-9

[153] Moreira LM,Hulsurkar M.Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia.Nature2020;587:460-5

[154] Gao XY,Luo XS.Acetyltransferase p300 regulates atrial fibroblast senescence and age-related atrial fibrosis through p53/Smad3 axis.Aging Cell2023;22:e13743 PMCID:PMC9835568

[155] Ghosh AK.Acetyltransferase p300 is a putative epidrug target for amelioration of cellular aging-related cardiovascular disease.Cells2021;10:2839 PMCID:PMC8616404

[156] Li Y,Cao W.Ezh2 inhibits replicative senescence of atrial fibroblasts through promotion of H3K27me3 in the promoter regions of CDKN2a and Timp4 genes.J Inflamm Res2022;15:4693-708 PMCID:PMC9392478

[157] Kinser HE.MicroRNAs as modulators of longevity and the aging process.Hum Genet2020;139:291-308 PMCID:PMC6954352

[158] Adam O,Thum T.Role of miR-21 in the pathogenesis of atrial fibrosis.Basic Res Cardiol2012;107:278

[159] Jazbutyte V,Kneitz S.MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart.Age2013;35:747-62 PMCID:PMC3636396

[160] Luo X,Shan H.MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation.J Clin Invest2013;123:1939-51 PMCID:PMC3635715

[161] Yuan K,Wang L.Molecular mechanism of atrial remodeling in patients with aging atrial fibrillation under the expression of microRNA-1 and microRNA-21.Bioengineered2021;12:12905-16 PMCID:PMC8810186

[162] Reilly SN,Carnicer R.Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase.Sci Transl Med2016;8:340ra74 PMCID:PMC4993239

[163] Martinez EC,Wang P.MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.J Mol Cell Cardiol2017;112:27-39

[164] Huang S,Song J.Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model.J Cell Physiol2019;234:2997-3006

[165] Ames MK,Pitt B.The renin-angiotensin-aldosterone system and its suppression.J Vet Intern Med2019;33:363-82 PMCID:PMC6430926

[166] Wo Y,Li P,Wo J.Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93.Cardiovasc Pathol2018;35:29-36

[167] Wang K,Zhou LY.The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.Circ Res2014;114:1377-88

[168] Trembinski DJ,Theodorou K.Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction.Nat Commun2020;11:2039 PMCID:PMC7184724

[169] Zangrando J,Vausort M.Identification of candidate long non-coding RNAs in response to myocardial infarction.BMC Genomics2014;15:460 PMCID:PMC4070571

[170] Zhu Y,Wang X.RNA-based therapeutics: an overview and prospectus.Cell Death Dis2022;13:644 PMCID:PMC9308039

[171] Paunovska K,Dahlman JE.Drug delivery systems for RNA therapeutics.Nat Rev Genet2022;23:265-80 PMCID:PMC8724758

[172] Brundel BJ,Ke L,Crijns HJ.Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.J Mol Cell Cardiol2006;41:555-62

[173] van Marion DMS,Hoogstra-Berends F.Oral geranylgeranylacetone treatment increases heat shock protein expression in human atrial tissue.Heart Rhythm2020;17:115-22

[174] Brundel BJ,Qi X.Induction of heat shock response protects the heart against atrial fibrillation.Circ Res2006;99:1394-402

[175] Versaci F,Forte M.Aging-related decline of autophagy in patients with atrial fibrillation-a post hoc analysis of the ATHERO-AF study.Antioxidants2022;11:698 PMCID:PMC9030744

[176] Wiersma M,Qi XY.Endoplasmic reticulum stress is associated with autophagy and cardiomyocyte remodeling in experimental and human atrial fibrillation.J Am Heart Assoc2017;6:e006458 PMCID:PMC5721854

[177] Brundel BJ,van Gelder IC.Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.Cardiovasc Res2002;54:380-9

[178] Nixon RA.The calpains in aging and aging-related diseases.Ageing Res Rev2003;2:407-18

[179] Hägg S.Sex differences in biological aging with a focus on human studies.Elife2021;10:e63425 PMCID:PMC8118651

[180] Odening KE,Dilling-Boer D.Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling.Europace2019;21:366-76

[181] Roberts JD,Lu AT.Epigenetic age and the risk of incident atrial fibrillation.Circulation2021;144:1899-911 PMCID:PMC8671333

[182] Quach A,Tanaka T.Epigenetic clock analysis of diet, exercise, education, and lifestyle factors.Aging2017;9:419-46 PMCID:PMC5361673